Oddifact and Mabion Receive FDA Pre-IND Meeting Grant for RTX-NP in Immune Thrombocytopenia16 hours ago0 min readoddifact-and-mabion-receive-fda-pre-ind-meeting.pdfDownload PDF • 136KB
